Paradigm Diagnostics, Inc. — Form D/A
Paradigm Diagnostics, Inc. of PHOENIX, AZ, a company, filed a Form D amendment with the SEC on 2018-12-04. The offering totals $12.5M, of which $11.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-12-04
- Form: D/A
- Accession: 0001690852-18-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $12.5M
- Amount sold: $11.0M
- Remaining: $1.5M
- Investors: 12
- Date of first sale: 2016-11-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-275535
Issuer
- Name: Paradigm Diagnostics, Inc.
- CIK: 0001690852
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 445 N. 5TH STREET, PHOENIX, AZ, 85004
- Phone: 602-850-7000
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Robert Armknecht | Director | PHOENIX, AZ |
| Grace Colon | Director | NEWARK, CA |
| Erin Curley | Director | PHOENIX, AZ |
| David Mallery | Director | PHOENIX, AZ |
| Rodney Markin | Director | San Diego, CA |
| Carey Ng | Director | LOS ANGELES, CA |
| David Mallery | Executive Officer | PHOENIX, AZ |
| Scott Morris | Executive Officer | San Francisco, CA |
| David Neal | Executive Officer | Chapel Hill, NC |
Other filings by this issuer (3)
More